Craft

Abcam

Stock Price

$24

2023-12-15

Market Capitalization

$5.5 B

2023-12-15

Revenue

£361.7 M

FY, 2022

Abcam Summary

Company Summary

Overview
Abcam is a life sciences company that identifies and develops biological reagents and tools. The company provides antibodies, binders, and assays, including primary and secondary antibodies, ELISA and matched antibody pairs, knockout cell lines and lysates, multiplex assays, agonists, antagonists, activators, inhibitors, as well as proteins and peptides. Its products are applicable in research, drug discovery, and diagnostics.
Type
Public
Status
Active
Founded
1998
Website
http://abcam.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

Operating MetricsView all

Locations

15
36.4%

FY, 2020

Countries

130
7.1%

FY, 2020

Products

130K
6.6%

FY, 2020

LocationsView all

8 locations detected

  • Branford, CT

    United States

    688 E Main St

  • Burlingame, CA

    United States

    863 Mitten Rd

  • Cambridge, MA

    United States

    1 Kendall Sq B2304

  • Eugene, OR

    United States

    1850 Millrace Dr #1

  • Hangzhou Shi, Zhejiang Sheng

    China

    1418-32 Moganshan Rd, Gongshu Qu

  • Shanghai, Shanghai

    China

    Unit 5401, Bldg. 5, No. 338 Galileo Rd. Pudong

and 2 others

Abcam Financials

Summary Financials

Revenue (FY, 2022)
£361.7M
Gross profit (FY, 2022)
£324.4M
Net income (FY, 2022)
(£8.5M)
Cash (FY, 2022)
£89.0M
EBIT (FY, 2022)
(£10.1M)
Enterprise value
$5.7B

Footer menu